Successful Control of Massive Bleeding in a Child with Burkitt’s Lymphoma via a Biosimilar Recombinant Activated Factor VII (AryoSeven™)
We describe a case of a 4-year-old girl with Burkitt’s lymphoma, who suffered from a massive gastrointestinal hemorrhage 3 days after chemotherapy. In spite of applying the common practice in correction of coagulopathy, thrombocytopenia persisted and bleeding became life-threatening. In the present...
Saved in:
| Main Authors: | Kourosh Goudarzi Pour, Fatemeh Malek, Peyman Eshghi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Case Reports in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2016/1295092 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recombinant factor VII (NovoSeven) in intraoperative blood saving during neurosurgical treatment of the brain arteriovenous malformation
by: Novak Vesna, et al.
Published: (2007-01-01) -
Comparative Efficacy of Recombinant FVIII and Recombinant FVII Biosimilars in Severe Hemophilia A
by: Meganathan Kannan PhD, et al.
Published: (2025-03-01) -
Use of recombinant factor VIIa in the treatment of massive retroperitoneal bleeding due to severe necrotizing pancreatitis
by: Stefanović Branislav, et al.
Published: (2009-01-01) -
High Dose, Prolonged Epsilon Aminocaproic Acid Infusion, and Recombinant Factor VII for Massive Postoperative Retroperitoneal Hemorrhage following Splenectomy
by: Alex T. Lee, et al.
Published: (2016-01-01) -
Burkitt Lymphoma of Thyroid Gland in an Adolescent
by: K. Cooper, et al.
Published: (2014-01-01)